Treatment with Soat2 siRNA/CS‐PLGA nanoparticles was capable to inhibit SOAT2 in enterocytes, which would be adequate to prevent the development of high‐fat diet induced obesity. This evidence concerns the gene SOAT2 and obesity due to melanocortin 4 receptor deficiency.